| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 7.46e-06 | 3 | 32 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 2.24e-04 | 14 | 32 | 2 | GO:0070679 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 3.75e-04 | 18 | 32 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 6.16e-04 | 23 | 32 | 2 | GO:0005283 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 6.27e-04 | 105 | 32 | 3 | GO:0015171 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 9.83e-04 | 29 | 32 | 2 | GO:0005416 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.12e-03 | 31 | 32 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.27e-03 | 33 | 32 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 1.43e-03 | 35 | 32 | 2 | GO:0005343 | |
| GeneOntologyMolecularFunction | symporter activity | 1.76e-03 | 150 | 32 | 3 | GO:0015293 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 1.96e-03 | 41 | 32 | 2 | GO:0015175 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 3.43e-03 | 190 | 32 | 3 | GO:0004252 | |
| GeneOntologyMolecularFunction | O-acyltransferase activity | 4.02e-03 | 59 | 32 | 2 | GO:0008374 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 4.36e-03 | 207 | 32 | 3 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 4.66e-03 | 212 | 32 | 3 | GO:0017171 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 4.73e-03 | 430 | 32 | 4 | GO:0004175 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 6.23e-03 | 465 | 32 | 4 | GO:0046873 | |
| GeneOntologyBiologicalProcess | gastrulation with mouth forming second | 2.15e-05 | 35 | 32 | 3 | GO:0001702 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 8.64e-05 | 9 | 33 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 1.32e-04 | 11 | 33 | 2 | GO:0031094 | |
| MousePheno | abnormal food preference | 7.61e-06 | 19 | 29 | 3 | MP:0001432 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 4.78e-06 | 19 | 33 | 3 | PS50267 | |
| Domain | SNF | 4.78e-06 | 19 | 33 | 3 | PF00209 | |
| Domain | Na/ntran_symport | 4.78e-06 | 19 | 33 | 3 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 4.78e-06 | 19 | 33 | 3 | PS00610 | |
| Domain | InsP3_rcpt-bd | 9.07e-06 | 3 | 33 | 2 | IPR000493 | |
| Domain | RIH_assoc | 4.52e-05 | 6 | 33 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 4.52e-05 | 6 | 33 | 2 | IPR013662 | |
| Domain | RYDR_ITPR | 4.52e-05 | 6 | 33 | 2 | PF01365 | |
| Domain | RIH_dom | 4.52e-05 | 6 | 33 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 4.52e-05 | 6 | 33 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 4.52e-05 | 6 | 33 | 2 | IPR015925 | |
| Domain | Ins145_P3_rec | 4.52e-05 | 6 | 33 | 2 | PF08709 | |
| Domain | - | 4.52e-05 | 6 | 33 | 2 | 1.25.10.30 | |
| Domain | MIR | 1.35e-04 | 10 | 33 | 2 | PS50919 | |
| Domain | MIR | 1.35e-04 | 10 | 33 | 2 | PF02815 | |
| Domain | MIR | 1.35e-04 | 10 | 33 | 2 | SM00472 | |
| Domain | MIR_motif | 1.35e-04 | 10 | 33 | 2 | IPR016093 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 4.55e-04 | 18 | 33 | 2 | PS00754 | |
| Domain | TRYPSIN_SER | 5.32e-04 | 90 | 33 | 3 | IPR033116 | |
| Domain | SRCR | 6.23e-04 | 21 | 33 | 2 | PF00530 | |
| Domain | TRYPSIN_HIS | 7.88e-04 | 103 | 33 | 3 | IPR018114 | |
| Domain | TRYPSIN_SER | 8.57e-04 | 106 | 33 | 3 | PS00135 | |
| Domain | TRYPSIN_HIS | 8.80e-04 | 107 | 33 | 3 | PS00134 | |
| Domain | SR | 8.85e-04 | 25 | 33 | 2 | SM00202 | |
| Domain | - | 8.85e-04 | 25 | 33 | 2 | 3.10.250.10 | |
| Domain | SRCR_1 | 9.58e-04 | 26 | 33 | 2 | PS00420 | |
| Domain | SRCR-like_dom | 9.58e-04 | 26 | 33 | 2 | IPR017448 | |
| Domain | SRCR_2 | 9.58e-04 | 26 | 33 | 2 | PS50287 | |
| Domain | Peptidase_S1A | 1.03e-03 | 113 | 33 | 3 | IPR001314 | |
| Domain | SRCR | 1.03e-03 | 27 | 33 | 2 | IPR001190 | |
| Domain | TRYPSIN_DOM | 1.08e-03 | 115 | 33 | 3 | PS50240 | |
| Domain | Tryp_SPc | 1.14e-03 | 117 | 33 | 3 | SM00020 | |
| Domain | Trypsin | 1.26e-03 | 121 | 33 | 3 | PF00089 | |
| Domain | Trypsin_dom | 1.26e-03 | 121 | 33 | 3 | IPR001254 | |
| Domain | Peptidase_S1_PA | 1.32e-03 | 123 | 33 | 3 | IPR009003 | |
| Domain | Cys-rich_flank_reg_C | 1.10e-02 | 90 | 33 | 2 | IPR000483 | |
| Domain | LRRCT | 1.10e-02 | 90 | 33 | 2 | SM00082 | |
| Domain | EGF_Ca-bd_CS | 1.27e-02 | 97 | 33 | 2 | IPR018097 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 5.95e-06 | 19 | 27 | 3 | MM15107 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 5.95e-06 | 19 | 27 | 3 | M27362 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 3.52e-05 | 5 | 27 | 2 | M49000 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 5.27e-05 | 6 | 27 | 2 | M47960 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 1.26e-04 | 9 | 27 | 2 | M47852 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.57e-04 | 10 | 27 | 2 | M47661 | |
| Pathway | WP_SARSCOV2_AND_COVID19_PATHWAY | 1.57e-04 | 10 | 27 | 2 | M40050 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.92e-04 | 11 | 27 | 2 | M49033 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 1.92e-04 | 11 | 27 | 2 | M27466 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 2.72e-04 | 13 | 27 | 2 | M47751 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.72e-04 | 13 | 27 | 2 | M47656 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.72e-04 | 13 | 27 | 2 | M47696 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 2.72e-04 | 13 | 27 | 2 | MM14553 | |
| Pathway | WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY | 3.71e-04 | 74 | 27 | 3 | M48080 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 4.01e-04 | 76 | 27 | 3 | MM15072 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 4.17e-04 | 16 | 27 | 2 | M26945 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 5.38e-04 | 84 | 27 | 3 | M27334 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 5.92e-04 | 19 | 27 | 2 | M47760 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 5.92e-04 | 19 | 27 | 2 | M27423 | |
| Pathway | REACTOME_ATTACHMENT_AND_ENTRY | 5.92e-04 | 19 | 27 | 2 | M41729 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 5.92e-04 | 19 | 27 | 2 | M47733 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 6.57e-04 | 20 | 27 | 2 | MM15485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 6.57e-04 | 20 | 27 | 2 | M47688 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 7.25e-04 | 21 | 27 | 2 | M27736 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 7.25e-04 | 21 | 27 | 2 | M47689 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 7.97e-04 | 22 | 27 | 2 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 7.97e-04 | 22 | 27 | 2 | M47675 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 8.72e-04 | 23 | 27 | 2 | M47676 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.03e-03 | 25 | 27 | 2 | MM14511 | |
| Pathway | WP_COVID19_STRUCTURAL_COVERAGE_MAP | 1.12e-03 | 26 | 27 | 2 | M48318 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.20e-03 | 27 | 27 | 2 | M12123 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.20e-03 | 27 | 27 | 2 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.29e-03 | 28 | 27 | 2 | M924 | |
| Pathway | WP_FRAGILE_X_SYNDROME | 1.55e-03 | 121 | 27 | 3 | M39804 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 1.69e-03 | 32 | 27 | 2 | MM14983 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 2.14e-03 | 36 | 27 | 2 | M1315 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 2.14e-03 | 36 | 27 | 2 | M39831 | |
| Pathway | REACTOME_EARLY_SARS_COV_2_INFECTION_EVENTS | 2.26e-03 | 37 | 27 | 2 | M45028 | |
| Pathway | WP_NRF2_PATHWAY | 2.40e-03 | 141 | 27 | 3 | M39454 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 2.77e-03 | 41 | 27 | 2 | M512 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 2.83e-03 | 314 | 27 | 4 | M39428 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 2.90e-03 | 42 | 27 | 2 | M791 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 3.18e-03 | 44 | 27 | 2 | M39845 | |
| Pathway | SIG_CHEMOTAXIS | 3.32e-03 | 45 | 27 | 2 | M5193 | |
| Pathway | SIG_BCR_SIGNALING_PATHWAY | 3.47e-03 | 46 | 27 | 2 | M8626 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 4.09e-03 | 50 | 27 | 2 | M47951 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 4.58e-03 | 53 | 27 | 2 | MM15716 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 4.75e-03 | 54 | 27 | 2 | MM15202 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 4.75e-03 | 54 | 27 | 2 | M27460 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 4.75e-03 | 54 | 27 | 2 | M26911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 4.93e-03 | 55 | 27 | 2 | M47952 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 6.03e-03 | 61 | 27 | 2 | MM15071 | |
| Pathway | REACTOME_CA2_PATHWAY | 6.22e-03 | 62 | 27 | 2 | M27321 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 6.94e-03 | 646 | 27 | 5 | MM14962 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 7.23e-03 | 67 | 27 | 2 | MM15327 | |
| Pubmed | Mutational analysis of the ligand binding site of the inositol 1,4,5-trisphosphate receptor. | 8.73e-07 | 2 | 33 | 2 | 8663526 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 15890645 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 20813840 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 7559486 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 20843799 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 1374893 | ||
| Pubmed | Distinct roles of inositol 1,4,5-trisphosphate receptor types 1 and 3 in Ca2+ signaling. | 8.73e-07 | 2 | 33 | 2 | 14707143 | |
| Pubmed | The repertoire of solute carriers of family 6: identification of new human and rodent genes. | 1.02e-06 | 21 | 33 | 3 | 16125675 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 31979185 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 10874040 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 9808793 | ||
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 2.62e-06 | 3 | 33 | 2 | 24904548 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 12421829 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 20395455 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 25103283 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 17327232 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 22992961 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 17437169 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 16014380 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 18194433 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 17890015 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 18547250 | ||
| Pubmed | Selected SALM (synaptic adhesion-like molecule) family proteins regulate synapse formation. | 2.62e-06 | 3 | 33 | 2 | 20410109 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 36350267 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 12032348 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 18250332 | ||
| Pubmed | IP3 receptors regulate vascular smooth muscle contractility and hypertension. | 2.62e-06 | 3 | 33 | 2 | 27777977 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 11413485 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. | 2.62e-06 | 3 | 33 | 2 | 23983250 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 29370841 | ||
| Pubmed | Synaptic adhesion-like molecules (SALMs) promote neurite outgrowth. | 2.62e-06 | 3 | 33 | 2 | 18585462 | |
| Pubmed | Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes. | 2.62e-06 | 3 | 33 | 2 | 9858485 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 26009177 | ||
| Pubmed | Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line. | 2.62e-06 | 3 | 33 | 2 | 17581770 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 20427533 | ||
| Pubmed | Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction. | 2.62e-06 | 3 | 33 | 2 | 18241669 | |
| Pubmed | Receptor-activated single channels in intact human platelets. | 2.62e-06 | 3 | 33 | 2 | 1693919 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 19068129 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 23955339 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 25215520 | ||
| Pubmed | Regulation of InsP3 receptor activity by neuronal Ca2+-binding proteins. | 5.23e-06 | 4 | 33 | 2 | 14685260 | |
| Pubmed | Inositol 1, 4, 5-trisphosphate receptor interacts with the SNARE domain of syntaxin 1B. | 5.23e-06 | 4 | 33 | 2 | 21424589 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 25497732 | ||
| Pubmed | Ins(1,4,5)P3 receptor-mediated Ca2+ signaling and autophagy induction are interrelated. | 5.23e-06 | 4 | 33 | 2 | 22082873 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 28419336 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 11163362 | ||
| Pubmed | IP3R-mediated Ca2+ signaling controls B cell proliferation through metabolic reprogramming. | 5.23e-06 | 4 | 33 | 2 | 35494252 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 28615414 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 11524429 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 10828023 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 23884412 | ||
| Pubmed | InsP₃receptors and Orai channels in pancreatic acinar cells: co-localization and its consequences. | 8.72e-06 | 5 | 33 | 2 | 21568942 | |
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 19706527 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 8081710 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 15613488 | ||
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 23463619 | ||
| Pubmed | Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release. | 1.31e-05 | 6 | 33 | 2 | 21762810 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 1.31e-05 | 6 | 33 | 2 | 16844763 | |
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 1.31e-05 | 6 | 33 | 2 | 25966694 | |
| Pubmed | Genetic evidence supporting caveolae microdomain regulation of calcium entry in endothelial cells. | 1.31e-05 | 6 | 33 | 2 | 17416589 | |
| Pubmed | 1.83e-05 | 7 | 33 | 2 | 16828986 | ||
| Pubmed | 1.83e-05 | 7 | 33 | 2 | 11860456 | ||
| Pubmed | Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. | 1.83e-05 | 7 | 33 | 2 | 22495310 | |
| Pubmed | A novel family of adhesion-like molecules that interacts with the NMDA receptor. | 1.83e-05 | 7 | 33 | 2 | 16495444 | |
| Pubmed | 3.13e-05 | 9 | 33 | 2 | 15623527 | ||
| Pubmed | 3.13e-05 | 9 | 33 | 2 | 25737585 | ||
| Pubmed | Signal relay by BMP antagonism controls the SHH/FGF4 feedback loop in vertebrate limb buds. | 3.91e-05 | 10 | 33 | 2 | 10524628 | |
| Pubmed | Type 1 and 3 inositol trisphosphate receptors are required for extra-embryonic vascular development. | 4.78e-05 | 11 | 33 | 2 | 27514653 | |
| Pubmed | 6.77e-05 | 13 | 33 | 2 | 17724084 | ||
| Pubmed | 7.89e-05 | 14 | 33 | 2 | 34630045 | ||
| Pubmed | Inositol 1,4,5-trisphosphate receptors are essential for the development of the second heart field. | 7.89e-05 | 14 | 33 | 2 | 21382375 | |
| Pubmed | Synergistic Signaling by Light and Acetylcholine in Mouse Iris Sphincter Muscle. | 9.10e-05 | 15 | 33 | 2 | 28578927 | |
| Pubmed | 1.18e-04 | 17 | 33 | 2 | 15148151 | ||
| Pubmed | Foxn4 controls the genesis of amacrine and horizontal cells by retinal progenitors. | 1.48e-04 | 19 | 33 | 2 | 15363391 | |
| Pubmed | 1.81e-04 | 21 | 33 | 2 | 19592578 | ||
| Pubmed | 1.99e-04 | 22 | 33 | 2 | 14645517 | ||
| Pubmed | 1.99e-04 | 22 | 33 | 2 | 11696558 | ||
| Pubmed | 2.38e-04 | 24 | 33 | 2 | 10843712 | ||
| Pubmed | SALM4 suppresses excitatory synapse development by cis-inhibiting trans-synaptic SALM3-LAR adhesion. | 2.58e-04 | 25 | 33 | 2 | 27480238 | |
| Pubmed | 2.58e-04 | 25 | 33 | 2 | 22411557 | ||
| Pubmed | 3.25e-04 | 28 | 33 | 2 | 24491816 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | 3.45e-04 | 1016 | 33 | 6 | 19056867 | |
| Pubmed | 3.49e-04 | 29 | 33 | 2 | 32123907 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | 4.54e-04 | 1070 | 33 | 6 | 23533145 | |
| Pubmed | 4.81e-04 | 34 | 33 | 2 | 18848646 | ||
| Pubmed | 5.39e-04 | 36 | 33 | 2 | 30571485 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 6.01e-04 | 38 | 33 | 2 | 30786075 | |
| Pubmed | Prospective isolation and global gene expression analysis of definitive and visceral endoderm. | 8.80e-04 | 46 | 33 | 2 | 17328885 | |
| Cytoband | 11q13.2 | 5.31e-04 | 47 | 33 | 2 | 11q13.2 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 5.96e-06 | 3 | 26 | 2 | 297 | |
| GeneFamily | Proteases, serine | 3.68e-03 | 63 | 26 | 2 | 738 | |
| GeneFamily | Solute carriers | 1.85e-02 | 395 | 26 | 3 | 752 | |
| GeneFamily | Fibronectin type III domain containing | 2.20e-02 | 160 | 26 | 2 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.23e-02 | 161 | 26 | 2 | 593 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.77e-02 | 181 | 26 | 2 | 694 | |
| Coexpression | CHESLER_BRAIN_D6MIT150_QTL_CIS | 2.30e-05 | 6 | 33 | 2 | MM607 | |
| Coexpression | CHESLER_BRAIN_D6MIT150_QTL_CIS | 2.30e-05 | 6 | 33 | 2 | M12143 | |
| Coexpression | ESC_V6.5_UP_LATE.V1_UP | 8.20e-05 | 184 | 33 | 4 | M2772 | |
| Coexpression | ESC_J1_UP_LATE.V1_UP | 8.55e-05 | 186 | 33 | 4 | M2768 | |
| Coexpression | GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP | 1.13e-04 | 200 | 33 | 4 | M7841 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.06e-05 | 97 | 33 | 3 | a1279377bf0ee5662db8b9303f5f1fd418dee6df | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.06e-05 | 97 | 33 | 3 | 12cbd03b33e76e5e471bbee2a9c11f27e8b21123 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Slc17a7.Cplx3_(Cortical_subplate)|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.22e-05 | 104 | 33 | 3 | 59e982b521610af0532c63b2caf934fa65644b0b | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Slc17a7.Cplx3_(Cortical_subplate)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.22e-05 | 104 | 33 | 3 | 7642c6ac1a51b431a8d48d35520930c072a3710e | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Slc17a7.Cplx3_(Cortical_subplate)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.22e-05 | 104 | 33 | 3 | 016704f1d1c43e6d4067ad1d81c22cc660e605d0 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_D|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.81e-04 | 149 | 33 | 3 | dcf68eb25733b5db2893728fe4dca5c7267eb58c | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.95e-04 | 153 | 33 | 3 | e7d20c88466ff81db613869cf7a6a4bb95fd6c2f | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 156 | 33 | 3 | 5caefdc6cc86f2ac52abe8c8da821db14f476915 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 156 | 33 | 3 | 758f57dc10fc5cad200bf5b310c10ec9b1405f23 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal-GABAergic_neurons|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.39e-04 | 164 | 33 | 3 | 4d7b2d0980fb4f47721fa2891151e2bd892ccb91 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-04 | 171 | 33 | 3 | 285533ca2a6a411773313166bee35542f34d1a3c | |
| ToppCell | 368C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.80e-04 | 173 | 33 | 3 | 8cffb4a37d30b6626188309b868ac4a62e91262f | |
| ToppCell | 368C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.80e-04 | 173 | 33 | 3 | fb87ea74bf70aa83b458edf728c81857c8b8eb96 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-04 | 176 | 33 | 3 | b81e5d23b31cefc8d374ef403e21acc390c14a80 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-04 | 176 | 33 | 3 | 057d2759fdc67176c25802b57a78064d8cc93205 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-04 | 177 | 33 | 3 | 43dce527392f3b8364bb6a55268ce9d6518d3a29 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.20e-04 | 181 | 33 | 3 | c1203787cc3f968147fabdd3c646a04be96f6552 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.20e-04 | 181 | 33 | 3 | f7258af89f4cc89446ff6754bdaa769320af95d6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.30e-04 | 183 | 33 | 3 | f8b636391f752e379a5c5575fd898bdf0907a3b8 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-04 | 183 | 33 | 3 | d26c7b79895de28961b8d68351f28d4bb531c75c | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-04 | 183 | 33 | 3 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | droplet-Heart-4Chambers-21m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-04 | 183 | 33 | 3 | a046b569bc10083d471b420eb2c6fee93437602d | |
| ToppCell | droplet-Heart-4Chambers-21m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-04 | 183 | 33 | 3 | 4de2082dca2569d3aac3c9b466f27971c82d302b | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 184 | 33 | 3 | 3da93e7d8b62463e307cc0425c47dbd3bef66799 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 185 | 33 | 3 | 554c5d812197fbf66bf279fcc953277e926ade15 | |
| ToppCell | facs-Heart-LV-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 185 | 33 | 3 | a835f821a5e6568d648df831ec4c2d0048d67093 | |
| ToppCell | facs-Heart-LV-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 185 | 33 | 3 | 386b08bcb304db543e3c5ff75f85e99bf0c592df | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.46e-04 | 186 | 33 | 3 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.52e-04 | 187 | 33 | 3 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.52e-04 | 187 | 33 | 3 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.57e-04 | 188 | 33 | 3 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.57e-04 | 188 | 33 | 3 | c2321a3a1d9603f8b4b4fc09707eb32ec1e04f3f | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 3.63e-04 | 189 | 33 | 3 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | pdx-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.68e-04 | 190 | 33 | 3 | b05db0de9b6ae01dd30074453f7de44f7397631e | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-04 | 191 | 33 | 3 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.80e-04 | 192 | 33 | 3 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-04 | 192 | 33 | 3 | 3e1a4cb0d83efd502c8613d41a1692bdda5860ed | |
| ToppCell | 356C-Epithelial_cells|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.97e-04 | 195 | 33 | 3 | d913d0a6c4797d9a873ddea6f340c3f152da1cf3 | |
| ToppCell | (7)_Epithelial-A_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.97e-04 | 195 | 33 | 3 | c9a6c65ee18d83bf34a4713d306a6e30db1325c2 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.09e-04 | 197 | 33 | 3 | ee8f7def9d5af7b1e636830a4ea1da158d02f25a | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.16e-04 | 198 | 33 | 3 | 3222d064b6ecab0caa450a59fc1dc79e26fc6fd5 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-AT2|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.22e-04 | 199 | 33 | 3 | 5323d49d3be980605b3e609b7f03bddba6e50e8a | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_2_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.22e-04 | 199 | 33 | 3 | e28ace2ca680c6154398e17110aa1838dd7a5548 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.28e-04 | 200 | 33 | 3 | 35c05cae30cd6b323d2662f1396ddeab08bc75fc | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.28e-04 | 200 | 33 | 3 | 3c251ad03fbbdae91dfd9037880ba43adbb03807 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.28e-04 | 200 | 33 | 3 | c2bde99b3bc7a8740441c1a0c1394892b940b857 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.28e-04 | 200 | 33 | 3 | c905451425d1c24773bb0ca69bcf0309b277d2f1 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.28e-04 | 200 | 33 | 3 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.28e-04 | 200 | 33 | 3 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.28e-04 | 200 | 33 | 3 | 65c83a3f6ee2a10bcb5b95076696232c6373a7b4 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.28e-04 | 200 | 33 | 3 | 40e969883bc302e8fbc6b6ab9814529dc1472902 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.28e-04 | 200 | 33 | 3 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.28e-04 | 200 | 33 | 3 | 9970e9bde6aa2ff3aef60dcb065ff15b7463e147 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.28e-04 | 200 | 33 | 3 | 3ff9abd5e07780a59d5571da906fa15f00a1d5c2 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.28e-04 | 200 | 33 | 3 | ad9cdc82a647d379abc713a56db0e11bb6494106 | |
| ToppCell | Biopsy_Other_PF-Epithelial|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.28e-04 | 200 | 33 | 3 | 1ef4d5ae698fa721e0f510bf0d918bd8d3b00591 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.28e-04 | 200 | 33 | 3 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.28e-04 | 200 | 33 | 3 | 4c3c11dd5e71ebc3d62264eeaeb71a850b149779 | |
| Drug | Isocaffeine | 2.04e-06 | 2 | 33 | 2 | CID000001326 | |
| Drug | adenophostin B | 2.04e-06 | 2 | 33 | 2 | CID000656722 | |
| Drug | benzene 1,2,4-trisphosphate | 2.04e-06 | 2 | 33 | 2 | CID000192376 | |
| Drug | 5-deoxy-5-fluoro-myo-inositol | 6.11e-06 | 3 | 33 | 2 | CID000195110 | |
| Drug | AC1O43P4 | 6.24e-06 | 25 | 33 | 3 | CID006323279 | |
| Drug | Tyloxapol [25301-02-4]; Up 200; 4uM; PC3; HT_HG-U133A | 9.21e-06 | 198 | 33 | 5 | 4611_UP | |
| Drug | CHEBI:697555 | 1.22e-05 | 4 | 33 | 2 | CID009578246 | |
| Drug | AC1Q7BER | 3.04e-05 | 6 | 33 | 2 | CID000005702 | |
| Drug | 3-F-InsP3 | 4.26e-05 | 7 | 33 | 2 | CID003035756 | |
| Drug | Br2BAPTA | 4.26e-05 | 7 | 33 | 2 | CID003081001 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 4.26e-05 | 7 | 33 | 2 | CID009547999 | |
| Drug | ts M | 4.59e-05 | 48 | 33 | 3 | CID000428025 | |
| Drug | 9 mM of H | 5.67e-05 | 8 | 33 | 2 | CID000130464 | |
| Drug | basic copper carbonate | 5.67e-05 | 8 | 33 | 2 | CID000025503 | |
| Drug | Ns 004 | 5.67e-05 | 8 | 33 | 2 | CID000162750 | |
| Drug | F2 g | 5.67e-05 | 8 | 33 | 2 | CID006857713 | |
| Drug | clausenamide | 9.10e-05 | 10 | 33 | 2 | CID000128412 | |
| Drug | R 478 | 1.11e-04 | 11 | 33 | 2 | CID000084223 | |
| Drug | 8-amino-cADPR | 1.11e-04 | 11 | 33 | 2 | CID003081323 | |
| Drug | strontium | 1.30e-04 | 68 | 33 | 3 | CID000104798 | |
| Drug | retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A | 1.44e-04 | 185 | 33 | 4 | 6971_UP | |
| Drug | AC1NRA23 | 1.61e-04 | 73 | 33 | 3 | CID005287657 | |
| Drug | Trazodone hydrochloride [25332-39-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.76e-04 | 195 | 33 | 4 | 7452_UP | |
| Drug | Procyclidine hydrochloride [1508-76-5]; Down 200; 12.4uM; HL60; HT_HG-U133A | 1.79e-04 | 196 | 33 | 4 | 2991_DN | |
| Drug | Propofol [2078-54-8]; Up 200; 22.4uM; HL60; HT_HG-U133A | 1.83e-04 | 197 | 33 | 4 | 3048_UP | |
| Drug | Estropipate [7280-37-7]; Up 200; 9.2uM; HL60; HT_HG-U133A | 1.86e-04 | 198 | 33 | 4 | 2506_UP | |
| Drug | Cinoxacin [28657-80-9]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 1.90e-04 | 199 | 33 | 4 | 3463_DN | |
| Drug | Dapsone [80-08-0]; Up 200; 16.2uM; PC3; HT_HG-U133A | 1.90e-04 | 199 | 33 | 4 | 5078_UP | |
| Drug | valproate | 2.06e-04 | 381 | 33 | 5 | CID000003121 | |
| Drug | 11-trans-leukotriene E4 | 2.11e-04 | 80 | 33 | 3 | CID000003909 | |
| Drug | AC1L8KRN | 2.11e-04 | 15 | 33 | 2 | CID000403109 | |
| Drug | Gvapspat amide | 2.11e-04 | 15 | 33 | 2 | CID000125015 | |
| Drug | erucyl-CoA | 2.11e-04 | 15 | 33 | 2 | CID006443765 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 7.00e-05 | 12 | 31 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | obesity (implicated_via_orthology) | 7.39e-05 | 215 | 31 | 4 | DOID:9970 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 1.28e-04 | 93 | 31 | 3 | C1535926 | |
| Disease | Hyalinosis, Segmental Glomerular | 3.97e-04 | 28 | 31 | 2 | C0086432 | |
| Disease | Focal glomerulosclerosis | 6.58e-04 | 36 | 31 | 2 | C0017668 | |
| Disease | retinal vasculature measurement | 2.01e-03 | 517 | 31 | 4 | EFO_0010554 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GDRVPWARCRQAYFG | 386 | P50416 | |
| DGGAWVLGYRAGPAC | 646 | Q68DA7 | |
| DPCRGGAGHWNGLYR | 291 | Q14573 | |
| PDGAGRPWCFYGDAR | 141 | P56730 | |
| KWRRYNFGGHGDCGP | 31 | Q71F56 | |
| PCRGGAGYWNSLFRF | 291 | Q14643 | |
| GLGSFRCLCWPGYSG | 241 | Q5IJ48 | |
| AAPCWTGAGRGRYLP | 426 | Q8N158 | |
| RCHAANPNGRYYWGG | 436 | P02675 | |
| HGLPGYNAWRRFCGL | 566 | P11678 | |
| FALGCGGAARWYPRA | 106 | Q9NP08 | |
| YLARYPHGGCRGWDD | 981 | Q7Z7M0 | |
| GAARAGPGLSYCVWV | 1291 | Q7Z7M0 | |
| ACASPPALGGRYFWA | 271 | Q9BTN0 | |
| GFSPCIFWGRGLFSA | 261 | Q86VF5 | |
| LGAFLGAWPALCGRY | 221 | Q9NQ84 | |
| AAGPWRGFCAASRFF | 176 | Q8IZ08 | |
| RGGHWPYGAVGCRAL | 96 | Q9P296 | |
| GGIPYLWRLSGRFCG | 96 | O75844 | |
| ARGYQGWFHPCARLS | 6 | Q13268 | |
| AWRASGRPGYCLGTR | 51 | O75880 | |
| VCAGPGGFSEYVLWR | 276 | Q8N1G2 | |
| GFFRAIDCPYWSGAP | 6 | Q8N1G1 | |
| LGFCVGLGNVWRFPY | 46 | Q695T7 | |
| RVRGPYWMHFCGGSL | 56 | Q9BZJ3 | |
| AIGLGNVWRFPYLCG | 61 | P30531 | |
| AFEPRGWVFGGGLCH | 121 | P49683 | |
| GGLPYCHQAWLDFRR | 321 | Q58EX7 | |
| ADGPRGCRFAGQWFP | 866 | Q9H2X0 | |
| WGSGCAKAYRPGVYG | 461 | O15393 | |
| YCLQSRLWGRAGGPA | 96 | Q6T4P5 | |
| GNVWRFPYLCYRNGG | 121 | P48067 | |
| CAWGCRGSFIPARYN | 151 | Q2VWA4 | |
| AGCYGYARRLGGAWA | 591 | Q6PJG9 |